Akorn, Inc. FDA Record
- Latest inspection NAI · Mar 5, 2019
- Last warning letter 2012
Akorn, Inc. has 192 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Akorn, Inc., the most recent on Oct 2, 2012. FDA has published 11 Form 483s for Akorn, Inc..
- Latest recall
- D-0793-2023 · Class II · Apr 26, 2023
- Latest inspection
- Mar 5, 2019 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 192 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 6 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 1 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Akorn, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 87 | 0 |
| 2022 | 0 | 0 | 0 | 37 | 0 |
| 2021 | 0 | 0 | 0 | 7 | 0 |
| 2020 | 0 | 0 | 0 | 7 | 0 |
| 2019 | 1 | 0 | 0 | 15 | 0 |
| 2018 | 0 | 0 | 0 | 12 | 0 |
| 2017 | 2 | 0 | 0 | 7 | 0 |
Reviewing Akorn, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Akorn, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Akorn, Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Oct 2, 2012 · Record page |
Akorn, Inc. Form 483s
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0793-2023 | Class II | Cimetidine HCl Oral Solution 300mg/5mL, 237 mL bottles, Rx Only, Distributed by: Akorn Operating… | Apr 26, 2023 |
| D-0836-2023 | Class II | Prednisolone Oral Solution, USP, 15 mg/5 mL, packaged in a) 240 mL and b) 480 mL bottles, Rx Only… | Apr 26, 2023 |
| D-0781-2023 | Class II | Acetic Acid Otic Solution, 15 mL per bottle, Rx only, Distributed by: Akorn Operating Company LLC… | Apr 26, 2023 |
| D-0848-2023 | Class II | Sulfamethoxazole & Trimethoprim Oral Suspension USP, 200mg/40mg per 5mL, 473 mL bottles, Cherry… | Apr 26, 2023 |
| D-0800-2023 | Class II | Diuril (chlorothiazide sodium) Injection, 500mg/vial, Single-Dose Vial, Rx Only, Distributed by… | Apr 26, 2023 |
| D-0801-2023 | Class II | DOCU LIQUID (docusate sodium, 50 mg/5 mL), packaged in 473mL bottles and b)10mL Unit Dose cups… | Apr 26, 2023 |
| D-0839-2023 | Class II | Proparacaine HCl Ophthalmic Solution, USP 0.5%, 15 mL bottles, Rx Only, Distributed by: Akorn… | Apr 26, 2023 |
| D-0796-2023 | Class II | Clobetasol Propionate Shampoo, 0.05%, 4oz (118 mL) bottles, Rx Only, Distributed by: Akorn… | Apr 26, 2023 |
| D-0858-2023 | Class II | Calcitriol Injection 2 mcg/mL, 1 mL ampules Rx Only, Distributed by: Akorn Operating Company, LLC… | Apr 26, 2023 |
| D-0859-2023 | Class II | Midazolam Injection, USP, 50 mg/10mL (5mg/mL), For Intramuscular or Intravenous Use Only, 10 mL… | Apr 26, 2023 |
| D-0813-2023 | Class II | Ketorolac Tromethamine Ophthalmic Solution, 0.5%, Sterile, packaged in a) 3mL bottles, b bottles) 5… | Apr 26, 2023 |
| D-0806-2023 | Class II | Granisetron HCl Injection, USP, 1 mg/mL, packaged in a) 1mL and b) 4 mL vials, Rx Only, For… | Apr 26, 2023 |
| D-0803-2023 | Class II | Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles, Distributed by: Akorn Operating… | Apr 26, 2023 |
| D-0789-2023 | Class II | Calcipotriene Topical Solution, 0.005% (Scalp Solution), 60 mL bottles, Rx Only, Distributed by… | Apr 26, 2023 |
| D-0817-2023 | Class II | Levocarnitine Oral Solution, USP, 118 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL… | Apr 26, 2023 |
| D-0862-2023 | Class II | Pilocarpine Hydrochloride Ophthalmic Solution, USP 4%, 15 mL bottles, Rx Only, Sterile, Distributed… | Apr 26, 2023 |
| D-0840-2023 | Class II | Rifampin Capsules USP, 150 mg, 30-count bottles, Rx Only, Sterile, Distributed by: Akorn Operating… | Apr 26, 2023 |
| D-0833-2023 | Class II | Olopatadine HCl Ophthalmic Solution, USP, 0.1%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc… | Apr 26, 2023 |
| D-0820-2023 | Class II | Levofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by: Akorn, Inc., Lake… | Apr 26, 2023 |
| D-0860-2023 | Class II | Olopatadine HCl Ophthalmic Solution, USP, 0.2%, 5mL bottles, Rx Only, Sterile, Manufactured by… | Apr 26, 2023 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 5, 2019 | Gurnee, IL | Drugs | No Action Indicated (NAI) | 3003102962 |
| Mar 20, 2017 | Gurnee, IL | Drugs | No Action Indicated (NAI) | 3003102962 |
| Feb 13, 2017 | Gurnee, IL | Drugs | No Action Indicated (NAI) | 3003102962 |
| Dec 18, 2015 | Gurnee, IL | Drugs | No Action Indicated (NAI) | 3003102962 |
| Nov 10, 2015 | Vernon Hills, IL | Drugs | No Action Indicated (NAI) | 3008883167 |
| Nov 10, 2009 | Gurnee, IL | Drugs | Voluntary Action Indicated (VAI) | 3003102962 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 1 compliance action under Akorn, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003102962 | Gurnee, IL | 5 | Mar 5, 2019 |
| FEI 3008883167 | Vernon Hills, IL | 1 | Nov 10, 2015 |
Akorn, Inc. and the FDA: common questions
Has Akorn, Inc. received an FDA warning letter?
Yes. FDA has issued 1 warning letter to Akorn, Inc.. The most recent is dated Oct 2, 2012.
Has Akorn, Inc. received an FDA Form 483?
FDA has published 11 Form 483s for Akorn, Inc. in its reading room, the most recent dated Aug 30, 2018. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Akorn, Inc.?
The most recent FDA inspection on file ended Mar 5, 2019 at Gurnee, IL and was classified NAI. FDA has 6 inspections of Akorn, Inc. on file.
Has Akorn, Inc. had an FDA recall?
Yes. Akorn, Inc. has 192 FDA recalls on record. The most recent started Apr 26, 2023.
Need more than this page shows? Ask about Akorn, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.